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ABSTRACT 
Objectives: Cannabis and gambling are two common forms of impulsive behavior 
among young adults. Although both cannabis use and gambling have been associated 
with specific cognitive deficits on tasks related to decision making, no studies to date 
have examined the possible effects on neurocognition in those who simultaneously 
gamble and use cannabis.  
Methods: To address this question, the present study analyzed 214 subsyndromal 
gamblers from a larger study on impulsivity. Of these subjects, 64 (29.9%) were current 
cannabis users (last use within the last three months), and 150 (70.1%) of whom had no 
history of cannabis use in the last three months, along with 163 healthy controls. 
Participants were assessed on various cognitive and clinical measures, including 
measures for gambling severity and impulsivity. 
Results: Cannabis using subjects had higher rates of current alcohol use disorders and 
more frequent gambling behavior per week. Gamblers who used cannabis also exhibited 
significantly greater scores on one measure of attentional impulsivity. Both gambling 
groups differed from healthy controls on all clinical and select neurocognitive variables, 
consistent with previous research.  
Conclusions: These results indicate that cannabis use in young adults who gamble is 
associated with nuanced behavioral differences, although causality could not be 
determined. Longitudinal research should examine cannabis use in subsyndromal 
gamblers over time to characterize whether these findings are causative. 
Keywords: Cannabis; neurocognition; gambling; addiction   
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1. Introduction 
Cannabis is one of the most commonly used illegal drugs in the United States, with one 
national survey noting that 18.7% of young adults from 18-26 had used cannabis in the 
past month, and 31.50% had used it in the past year (NIDA Report, 2012). This high rate 
of use has spurred numerous investigations on the possible detrimental health effects of 
cannabis, including increased risk for psychosis, respiratory disorders, and various 
psychosocial problems (Roth et al., 1998; Fergusson et al., 2002; Arsenal et al., 2004). 
Additionally, research has demonstrated that cannabis has negative effects on various 
cognitive measures, including psychomotor speed, planning/sequencing ability, and 
memory (Makela et al., 2006; Medina et al., 2007; McHale & Hunt, 2008; Indlekofer et 
al., 2009; Gonzalez et al., 2012; Grant et al., 2012).  Studies have produced mixed results 
regarding the persistence of these cognitive differences following abstinence from 
cannabis. 
Cannabis use has also been associated with a higher risk for other potentially addictive or 
impulsive behaviors, including alcohol use, illicit drug use, and problematic gambling 
behavior (Carvalho et al., 2005; Fergusson et al., 2006; Wanner et al., 2006). Cannabis 
use also predicts higher rates of both alcohol use and illicit substance use later in life, 
with weekly or more frequent consumption indicating up to a twofold elevation in risk of  
high-risk drinking later in life (Fergusson et al., 2006; Patton et al., 2007). Other studies 
examining alcohol use and gambling have shown cognitive differences between 
pathological gambling substance abusers and controls, with alcohol abuse and 
pathological gambling producing an additive effect on risky choices during card/deck 
selection tasks (Petry, 2001). Other research has noted similar cognitive deficits between 
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alcohol dependence and pathological gambling on tasks such as the Tower of London and 
Stop Signal Task (Goudriaan et al., 2006). These similarities and interactions between 
other addictive behaviors suggest that comparable interactions may exist between related 
behaviors, such as gambling and cannabis. 
Knowledge regarding the effects of cannabis on gambling is been limited. The majority 
of research on cannabis and gambling has focused on rates of comorbidity between 
problem/pathological gamblers and cannabis use disorders, with one study finding that 
37.9% of treatment-seeking individuals with cannabis use disorders qualified for problem 
gambling, and another finding a prevalence of 18% in an adolescent sample (Petry & 
Tawfik, 2001; Toneatto & Brennan, 2002). The rates found in these studies are 
appreciably higher than estimated prevalence rates for problem gambling (0.4%-4.7%) 
(Shaffer et al., 1999; Stucki & Rihs-Middel, 2007). These elevated rates of gambling 
disorder are also consistent with studies collapsing across various forms of substance 
addiction, including alcohol, cocaine, and cannabis (Carvalhoe al., 2005). 
Although no studies to date have directly assessed the cognitive effects of cannabis on 
individuals who gamble, certain cognitive deficits in cannabis users and in gamblers may 
be relevant to this possible interaction. Previous studies of cannabis use have shown 
deficits in decision-making in response to negative consequences, high-risk betting 
tendencies, and discounting of delayed rewards on tasks such as the Iowa Gamble Task 
(IGT) and deck/card selection task (Whitlow et al, 2004; Wesley et al., 2011). Similarly, 
previous research in individuals who gamble has noted the following deficits: proportion 
of points bet and decision making based on risk on the Cambridge Gamble Task (CGT) 
(Grant et al., 2011).  Although no previous study to our knowledge has examined the 
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synergistic effects of cannabis use and gambling, related research on nicotine use found 
that it worsens gambling behaviors in those who smoke and gamble (Petry & Oncken, 
2002; Grant & Potenza, 2005) 
As both gambling and cannabis use are associated with cognitive deficits, recognizing the 
associations between cannabis use and current gambling symptomatology among 
individuals with subsyndromal gambling is important, as cannabis use may have 
implications for the clinical course of gambling. Based on these previous findings, we 
hypothesized that 1) cannabis use would be disproportionately common among 
individuals who gamble; 2) current cannabis use (past three months) would be associated 
with other substance use problems and worse gambling symptomatology; and 3) current 
cannabis use (past three months) would be associated with greater impulsivity and 
cognitive deficits in decision-making compared to subsyndromal gamblers who did not 
use cannabis as well as healthy controls. 
2. Methods 
2.1 Subjects 
For this analysis, 214 non-treatment-seeking young adults and 163 controls (ages 18-29) 
were selected from ongoing study examining impulsivity. To participate in the 
overarching study, subjects needed to be between the ages of 18-29, and have gambled at 
least 5 times in the past year. Subjects included in this sub-sample are drawn from the 
pool provided by the larger study on impulsivity and gambling, which includes 548 total 
subjects. Thus our sample consisted of 377 (68.8%) subjects from the overall sample, 
with 171 subjects excluded from analysis because they did not meet the criterion for 
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inclusion in the healthy control group or either of the gambling groups (criterion 
described below). Subjects were each compensated with a $50 gift card. Subsyndromal 
gambling was defined as having at least one but no more than 4 symptoms of 
pathological gambling based on the Structured Clinical Interview for Pathological 
Gambling (SCI-PG) (Grant et al., 2004). Healthy controls were defined as subjects with 
no cannabis use in the past 3 months, no current psychiatric diagnosis, and a score of zero 
on the SCI-PG. Subjects were excluded if they were unable to provide written informed 
consent.  
The study procedures were carried out in accordance with the Declaration of Helsinki. 
The Institutional Review Board of the University of Chicago approved the study and the 
accompanying consent form. After all procedures were explained, subjects provided 
informed written consent. 
2.2 Assessments 
2.2.1 Psychiatric Assessments 
Following consent procedures, all participants were screened using the Mini International 
Neuropsychiatric Inventory (MINI) (Sheehan et al., 1998) by trained raters. Additionally, 
all subjects completed general demographic information including age, race/ethnicity, 
education, and gender. 
2.2.2 Measures of Gambling Severity 
Structured Clinical Interview for Pathological Gambling (SCI-PG) (Grant et al., 2004): 
This diagnostic inventory assesses symptoms of pathological gambling. The criterion for 
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inclusion in the gambling groups was a score of 1-4 on this scale (i.e. a subsyndromal 
gambler). Scores greater than four or less than one were excluded from analysis. The 
SCI-PG captures various clinical aspects of gambling behavior. 
Pathological Gambling – Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS) 
(Pallanti et al., 2005): This clinician-administered instrument assesses thoughts, urges, 
and gambling behavior over the past seven days. This adaptation of the scale has been 
used to assess urges, thoughts, and overall severity specifically relating to gambling. The 
PG-YBOCS offers another assessment of gambling severity, providing a more specific 
account of obsessions and compulsions as they relate to gambling. (Pasche et al., 2013; 
Pallanti et al., 2005).  
2.2.3 Impulsivity Self-Report 
Barratt Impulsivity Scale, Version 11 (BIS-11) (Barratt, 1959; Patton et al., 1995): This is 
a valid, reliable, self-report inventory consisting of 30-items that measure distinct 
domains of impulsivity. The second order factors are defined as follows: motor 
impulsivity, attentional impulsivity, and non-planning impulsivity. This scale was 
included to assess self-reported levels of impulsivity, as cognitive impulsivity is a 
commonly cited factor in impulse control disorders, including gambling disorder, 
trichotillomania, and others. The self-report nature of the scale complements cognitive 
testing, as some studies have shown different levels of impulsivity between the two 
(Marazziti et al., 2014, Vonmoos et al., 2013). The three secondary measures were 
chosen to provide supplemental measures of impulsivity, thus further subdivisions of the 
categories were deemed unnecessary. 
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2.2.4 Neurocognitive Assessments 
Selected tasks from the Cambridge Neuropsychological Test Automated Battery were 
used for this study: Cambridge Gamble Task (CGT), Stop-Signal Task (SST), and 
Intra/Extradimentional Set Shift (IED). 
The CGT assesses risk-taking and decision making behavior. During the task, ten boxes 
(a mix of red and blue) are shown on the screen. During each set, the subject selects a 
rectangle at the bottom of the screen indicating “red” or “blue”. The subject’s choice 
indicates that they think a yellow token is hidden under the color they select. During all 
of the trials, the yellow token has an equal likelihood of appearing under any given 
colored box on the screen. After selecting a color, the subjects select a total number of 
points to wager on successfully finding the yellow token. Bet options appear in a new box 
on the screen and advance from 5% of total points up to 95% of total points. The overall 
proportion of possible points bet during the task is summarized by the “Overall 
proportion of points bet” variable. The greater the number of points bet, the higher risk 
the wager. Risk adjustment describes a person’s ability to adjust strategy in response to 
changes in the risk of a betting situation, and the likelihood that a given choice will be 
correct. Quality of decision making is related to the number of trials in which the subject 
chooses the color with the most total boxes on the screen, which is noted by the “Quality 
of decision making” variable. The “Delay aversion” variable accounts for individuals 
who are unable to wait for later options and select numbers earlier in both the ascending 
and descending sequences. 
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The SST examined the subject’s ability to inhibit a prepotent motor response. During the 
task, subjects are given a button box with two buttons. During the task, arrows appear in 
a circle on the screen, facing either right or left. When the arrows face left, the subject 
presses the left button on the box, and when the arrow faces right, the right button on the 
box. After 16 initial trials, the task changes slightly, and some of the arrows are followed 
by a beep. When the beep occurs, the subject is instructed not to press the key for the 
arrow that immediately preceded the beep. Greater stop signal reaction time during this 
task suggests a higher level of motor impulsivity and is summarized by the “SST SSRT 
(last half)” variable. 
The third task, the IED, assesses learning and cognitive flexibility. During the task, the 
subject views numerous sets of stimuli, with each set consisting of two blank boxes and 
two boxes with active stimuli. The computer has arbitrarily selected one stimulus as 
correct and the subject selects different stimuli in an attempt to learn the rule. On-screen 
feedback is provided after each choice, indicating if it was “correct” or “incorrect”. 
Following six consecutive correct selections, the computer automatically selects a new 
rule. During this phase, the subject must determine the new rule. Doing so with fewer 
errors indicates a higher level of learning and flexibility. The test consists of nine stages, 
although not all subjects complete all nine stages. For this reason, the primary outcome 
measure for this test is the adjusted number of total error. This adjustment accounts for 
the decreased number of stages completed for individuals unable to successfully select 
the “correct” options in six consecutive sets. 
The specific measures chosen for analysis were drawn from those specifically relating to 
impulsivity, gambling behavior, and quality of thinking. The descriptions provided here 
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provide a brief summary of the different tasks and variables used in this study. Full task 
descriptions can be found at www.camcog.com along with previous validations. 
2.2.5 Cannabis Use Assessment 
Data on cannabis use was collected verbally through a series of free response questions. 
The questions used were phrased as follows: 
1. Do you currently use cannabis/marijuana? 
2. How often per week or per month do you use cannabis/marijuana? 
3. When you use cannabis/marijuana, how much do you typically use? 
4. When was the last time you used cannabis/marijuana? 
If participants responded with “No” to the first question, they were not asked the 
remaining three. N values are limited for questions 3 and 4, as these questions were not 
added to the main study until later. The averages reported for the last two questions only 
include cannabis users who answered these questions during their first visit. Cannabis use 
was coded as frequency per week, for example, weekly use received a score of “1”, bi-
weekly use as a “.5”, and daily use as a “7”. 
 Nicotine use was identified with a question similar to #1. 
2.3 Data Analysis 
Subsyndromal gamblers were divided into two groups: “cannabis users” or “non-users”. 
The “cannabis users” group was defined as having used cannabis at least once in the past 
3 months, while the “non-users” group was defined by no cannabis use in the preceding 3 
months. Healthy controls were kept separate as the third comparison group. The subjects 
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included in this analysis were drawn from baseline results of an ongoing study on 
impulsivity, of which cannabis use was just one of the factors considered. 
ANOVA tests were used to examine age, impulsivity scales, gambling measures, and 
neurocognitive measures. Chi-square (Pearson’s) analyses were used for the remaining 
categorical variables. Further ANOVA and Chi-square analyses were conducted for 
significant results from the initial tests. As this was an exploratory study, significance 
was defined as p<.05, uncorrected. 
3. Results 
Of the 214 subsyndromal gamblers, 64 (30.0%) were current cannabis users. Both 
subsyndromal gambling groups differed significantly from controls in age (ANOVA: 
F=7.160, df=2; Cannabis: p<.05; No-cannabis: p=.001). The groups did not differ on any 
other demographic variables (Table 1). 
The 64 cannabis-using subsyndromal gamblers reported using cannabis an average of 
2.76 (±2.67) days per week. Of the 64 cannabis users, 20 reported their average amount 
consumed, with an average of .82g (±.77). Additionally, 27 cannabis users reported a specific 
last day of use, with an average of 6.17 (±11.92) days elapsed since last use. Data for quantity 
used and day of last used have lower N values because these measures were not added until later 
in the overarching study of impulsivity. 
In terms of co-occurring psychiatric disorders, the gamblers who also used cannabis were 
significantly more likely to have an alcohol use disorder (χ2 =21.829, df=1; p<.001). In 
general, the cannabis group was also significantly more likely to have any co-occurring 
psychiatric disorder (χ2=39.844, df=1; p<.001) (Table 2). All three groups differed 
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significantly on current nicotine use, with the cannabis group reporting the highest 
overall percentage current nicotine users, followed by the non-cannabis gamblers (χ2 
=22.099, df=2; p=.001). 
On measures of gambling severity, gamblers who used cannabis gambled significantly 
more times per week than other gamblers (F=4.628, df=1; p<.05), who in turn gambled 
more frequently than healthy controls (F=7.911; df=1; p<.05). The same pattern was 
found on the BIS measure of attentional impulsivity, with gamblers who used cannabis 
reporting higher levels than other gamblers (F=5.505, df=1; p<.05), and the non-cannabis 
using gamblers reporting higher levels than healthy controls. The gambling groups did 
not differ on any other gambling or impulsivity measures, but both differed significantly 
from healthy controls on all other clinical variables (summarized in Table 2). 
Both gambling groups differed significantly from healthy controls on measures of stop-
signal reaction time, proportion of points bet, quality of decision making, and risk 
adjustment (summarized in Table 3). The cannabis using gamblers did not differ 
significantly from the non-using gamblers on any of the cognitive tasks. 
4. Discussion 
This study examined the possible effects of cannabis use on gambling behavior and 
cognition in young adult subsyndromal gamblers relative to healthy controls. Consistent 
with our first hypothesis that rates of past-year cannabis use would be high among 
gamblers, we found that almost one-third of young adult gamblers were current cannabis 
users. This rate reflects a 60% increase in current cannabis use relative to the general 
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population of young adults age 18-25 (18.7%), and a 410% increase over all Americans 
over ages 12 and above (7.30%) (NIDA, 2012). 
Consistent with our second hypothesis, gamblers who used cannabis were significantly 
more likely to have an alcohol use disorder, other psychiatric diagnosis, and to be current 
nicotine users relative to subsyndromal gamblers who do not use cannabis. Results 
regarding the increased incidence of alcohol use disorders in cannabis users versus non-
users are consistent with previous research on cannabis use (Fergusson et al., 2006; 
Patton et al., 2007). These results suggest that several addictive behaviors seem to co-
occur. Even on the subsyndromal level of gambling behavior we see aggregation with 
other externalizing disorders such as alcohol dependence. Whether this reflects a shared 
pathophysiology, common genetic underpinning or environmental influences is not yet 
fully understood (Blanco et al., 2012; Grant et al., 2009; Slutske et al., 2000). 
Partly consistent with our second hypothesis was the finding that gamblers who used 
cannabis had worse gambling symptomatology on at least one measure - frequency of 
gambling per week. Cannabis was not associated with a stronger urge to gamble 
(reflected in no differences on the PG-YBOCS), which has been seen in gamblers who 
use nicotine (Grant & Potenza, 2005). These findings suggest one area in which cannabis 
may influence gambling behavior. For example, differences in gambling behavior but not 
thoughts or urges suggest that impairments in behavioral control might be related to the 
co-occurrence of cannabis use and gambling.  
As noted previously, nicotine use has previously been associated with higher urge scores 
on the PG-YBOCS scale, a relationship that was not found in this study, despite a 
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significantly higher rate of coexisting cannabis and nicotine use. This difference could 
suggest that cannabis moderates the effects that other substances have on gambling, such 
as nicotine’s cognitive implications. This interpretation would suggest that treatments 
emphasizing behavioral control might be particularly helpful for individuals with co-
existing gambling and cannabis use. The increased incidence of multiple externalizing 
disorders may indicate a third variable contributing to cannabis use, gambling, as well as 
other types of substance use. 
The possible association between cannabis use and gambling could also be mediated in 
multiple, non-mutually exclusive manners. For example, cannabis use may influence 
gambling through experiences of reward or pleasure that influence behavioral decision-
making. Alternatively, specific individuals (e.g., those who are more impulsive) may be 
predisposed to engage in both cannabis use and gambling. Due to the high incidence rate 
of alcohol use disorders, nicotine use, and comorbid MINI diagnoses, it was not possible 
to control for each of these significant differences. There are likely to be many 
overlapping vulnerability factors implicated in the etiology of both substance use and 
gambling. This study examined potential commonalities and differences between 
gamblers with and without cannabis use, and healthy controls.  Differences between 
cannabis users and non-users could be accounted for by factors other than cannabis use 
(for example, higher alcohol use disorder in the cannabis using group). To tease apart 
causality, larger scale studies would be needed, ideally incorporating a longitudinal 
design. We did not subdivide groups based on potential confounds because we wished to 
examine the ecological clinical and cognitive profiles of these groups as they presented. 
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Our third hypothesis was only partially supported by these data, and the findings are of 
note. First, cannabis users reported significantly higher levels of attentional impulsivity 
relative to both other gamblers and healthy controls. Previous research using the 
attentional impulsivity subscale has shown significantly higher levels of various 
impulsive and addictive behaviors, including pathological gambling, alcohol abuse, and 
illegal drug abuse (Kjome et al., 2010; Knezevic & Ledgerwood, 2012; Nielson et al., 
2012; Blackwell & Burke, 2013). From these results, we expected to find higher rates of 
attentional impulsivity in cannabis users, which was confirmed in this study. A higher 
level of attentional impulsivity in subsyndromal gamblers who use cannabis denotes a 
self-reported deficit in ability to focus on tasks and maintain attention for an extended 
period of time. As with other results, this is tempered by the high incidence of alcohol use 
disorders, but remains a significant point of consideration for clinicians working with 
comorbid cannabis use and gambling. 
In terms of neurocognitive findings, gamblers who used cannabis did not differ 
significantly from gamblers who did not use cannabis. Both groups did, however, 
perform significantly worse than healthy controls on measures of reaction time, quality of 
decision making, and risk adjustment. The similarities between the two gambling groups 
on neurocognitive tests does not generally support our hypothesis that cannabis use in 
subsyndromal gamblers would be associated with cognitive deficits. One measure of note 
was the proportion of points bet during the CGT. One explanation for the lack of 
significant differences between the gambling groups is that gambling is associated with 
such extreme cognitive deficits (Grant et al., 2011) that the addition of cannabis use does 
not appreciably worsen these deficits. As expected, a score of 1-4 on the SCI-PG scale 
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predicted a number of cognitive differences, and confirmed previous findings in gamblers 
compared with healthy controls (Grant et al., 2011). Further research is necessary to 
explore the relationship between gambling, cannabis use, and cognition, including the 
extent to which each behavior may contribute to the other's development and 
maintenance.  
These results highlight the idea that the potential interaction between cannabis and 
gambling is likely not a straight forward relationship. Rather, the absence of pervasive 
changes in neurocognitive factors suggests that the interaction between cannabis and 
subsyndromal gambling may produce more limited changes in neurocognition. 
Additionally, with increases in gambling severity isolated to frequency per week, it 
appears that cannabis may not have as drastic effect on gambling severity as was 
predicted. 
There are several limitations to this study that should be noted when interpreting its 
results. One possible limitation was that cannabis use was only considered over the 
preceding three months. Thus, we were unable to control for individuals with a history of 
cannabis use beyond the prior three months. Additionally, quantity of cannabis used at a 
time was not assessed for all subjects, as measures differed significantly between 
subjects, with no consistent measurement method. The relationship between potency and 
quantity is a common problem in research on cannabis and requires more precise 
measures. As a result of the self-report nature of the overarching study from which the 
subjects were drawn, it was not possible to determine cannabis potency or accurate 
quantity. In future studies, it would be advantageous to include standardized measures of 
quantity used in order to provide a better control of extraneous factors, with similar 
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consideration given to potency of the strains of cannabis (THC concentration). In self-
report studies, it is not possible to assess potency, thus future research hoping to control 
for quantity of the drug consumed would need to standardize both potency and quantity 
to sufficiently control for both. 
Similarly, the cross-sectional nature of this study inherently limited the conclusions that 
could be drawn from these results. Although this study provides a snapshot of this 
sample, it cannot differentiate between factors that were preexisting and those that may 
have been caused by cannabis use. A final consideration for the present study was the 
high degree of nicotine use and alcohol use disorders in the cannabis use group. Due to 
the prevalence of these disorders in the cannabis users, it was not feasible to selectively 
include individuals with no history of these problems. Future studies will likely benefit 
from controlling for these factors and limiting inclusion to individuals with no other 
substance abuse. 
5. Conclusions 
Ultimately, this study emphasizes the complex interaction between cannabis use and 
gambling behavior. Future studies will likely need to examine the roles that frequency of 
use, potency of the drug, and longitudinal factors play in this issue. Although the present 
study raises numerous questions, it offers some evidence that cannabis and gambling 
have a more subtle relationship than might be expected, meriting further investigation 
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